Giulia Guerra
Overview
Explore the profile of Giulia Guerra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agnoli C, Perlino F, Guerra G, Quartiroli M, Vener C, Mauri P, et al.
Int J Biol Markers
. 2025 Jan;
40(1):75-79.
PMID: 39834054
IntroductionBreast cancer is the most common cancer among women, and metabolic syndrome (MetS) is a risk factor for breast cancer, especially postmenopausal breast cancer. We evaluated the role of the...
2.
Piedimonte A, Volpino V, Campaci F, Borghesi F, Guerra G, Carlino E
Clin Pract
. 2024 Oct;
14(5):2151-2165.
PMID: 39451885
Background And Purpose: Treatment choice during clinical practice is crucial to best help each patient. One of the physicians' main goals is choosing a personalized effective treatment, but it also...
3.
Cao I, Bergonzoni E, Vedovelli L, Guerra G, Galletti L, Butera G, et al.
Pediatr Cardiol
. 2024 Sep;
PMID: 39287667
Despite the clinical results of the Fontan operation have certainly improved, it still presents with an inherent surgical risk of death and early morbidities. This is a retrospective clinical study...
4.
Pradegan N, Evangelista G, Tessari C, Guerra G, Toscano G, Gambino A, et al.
Kardiol Pol
. 2024 Sep;
82(12):1269-1271.
PMID: 39240917
No abstract available.
5.
Guerra G, Russo M, Priolo R, Riganti C, Reano S, Filigheddu N, et al.
Vascul Pharmacol
. 2024 Jul;
155:107324.
PMID: 38985581
Doxorubicin (DOX) is a highly effective chemotherapeutic agent whose clinical use is hindered by the onset of cardiotoxic effects, resulting in reduced ejection fraction within the first year from treatment...
6.
Guariento A, Cattapan C, Lorenzoni G, Guerra G, Doulamis I, Di Salvo G, et al.
Eur J Pediatr
. 2024 Apr;
183(7):2945-2954.
PMID: 38625387
Conclusions: A younger age at first admission is a predictor for mortality in patients with Down syndrome and congenital heart disease. If patients undergo more than one admission, the risk...
7.
De Luca I, Miliziano D, Guerra G, Colombo R, Morosi C, Sposito C, et al.
Heliyon
. 2024 Apr;
10(7):e28494.
PMID: 38596050
Purpose: To study plasma levels, efficacy and tolerability of imatinib in a patient affected by metastatic GIST treated with oral Imatinib and undergoing hemodialysis. Patients And Methods: The patient suffered...
8.
Guerra G, Segrado F, Pasanisi P, Bruno E, Lopez S, Raspagliesi F, et al.
Heliyon
. 2023 Nov;
9(11):e21921.
PMID: 38027764
Background: Given the growing interest in studying the role of choline and phosphocholine in the development and progression of tumor pathology, in this study we describe the development and validation...
9.
Guerra G, Fabozzo A, Ragona R, Gerosa G
JTCVS Tech
. 2022 Dec;
16:92-93.
PMID: 36510516
No abstract available.
10.
Brancaccio G, Trezzi M, Croci I, Guerra G, Chinali M, Grandinetti M, et al.
Eur J Cardiothorac Surg
. 2022 Mar;
62(4).
PMID: 35325092
Objectives: The aim of this study was to elucidate predictors of death and reintervention after mitral valve (MV) surgery in children. Methods: A single-centre retrospective study was performed enrolling 142...